Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Oncotarget|May 26, 2018
Combination of two anti-tubulin agents, eribulin and paclitaxel, enhances anti-tumor effects on triple-negative breast cancer through mesenchymal-epithelial transitionTakaaki Oba, Ken-Ichi Ito
Cancer Science|June 20, 2022
Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cellsKoichi Ohno, Tomohiro Shibata, Ken-Ichi Ito
Plos One|March 5, 2026
EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cellsTeruo Nakamura, Tomohiro Shibata, Ken-Ichi Ito
Journal of Clinical Medicine|January 21, 2023
The Advantage of Using an Optical See-Through Head-Mounted Display in Ultrasonography-Guided Needle Biopsy Procedures: A Prospective Randomized StudyTadafumi Shimizu, Takaaki Oba, Ken-Ichi Ito
Oncotarget|September 3, 2016
ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell linesTakaaki Oba, Hiroto Izumi, Ken-Ichi Ito
Breast Cancer Research and Treatment|September 21, 2023
Eribulin promotes proliferation of CD8+ T cells and potentiates T cell-mediated anti-tumor activity against triple-negative breast cancer cellsTadafumi Shimizu, Takaaki Oba, Masanori Oshi, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|March 16, 2018
Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of JapanIwao Sugitani, Naoyoshi Onoda, Ken-Ichi Ito, et al.
The Thoracic and Cardiovascular Surgeon Reports|November 1, 2014
A mediastinal liposarcoma resected using a double approach with a thoracoscopeShiho Asaka, Kazuo Yoshida, Mashiro Hashizume, et al.
Journal of Cancer Research and Clinical Oncology|July 10, 2021
The mechanisms involved in the resistance of estrogen receptor-positive breast cancer cells to palbociclib are multiple and change over timeMayu Ono, Takaaki Oba, Tomohiro Shibata, et al.
Oncotarget|March 7, 2019
FGF2-FGFR1 pathway activation together with thymidylate synthase upregulation is induced in pemetrexed-resistant lung cancer cellsKentaro Miura, Takaaki Oba, Kazutoshi Hamanaka, et al.
Pageof 12